Icertis closed $15M Series B; Khosla Ventures invested in Avametric; Constant Therapy raised $2M
- On-demand massage service, Soothe closed a $35 million Series B round of funding, led by the company's previous investor, The Riverside Company. With this round, Soothe has now raised a total of $47.7 million in funding to date. Soothe was founded in 2013 by CEO Merlin Kauffman, while he was at Harvard Business School. While traveling, he found it hard to find places to get massages in new cities, he told me in an in interview. "I grew up getting massages, and when I was traveling for business I would end up in cities where I found it challenging to book last minute massages, and I was often disappointed," he said. "So I saw a big gap in the market."
- Constant Therapy, an e-therapy app for patients suffering from head injuries, raised $2 million in Series A funding led by Golden Seeds with participation from Kapor Captial, Launchpad Venture Group, Pond Capital, and Community Health Network of Connecticut. Constant Therapy says it will use its new funding to continue infusing the app with new scientific research and data.
- Confide, a messaging platform that keeps everything confidential, closed a $1.6 million extension to their seed round, bringing total funding to $3.6 million. Investors include existing investors such as WGI Group, First Round Capital, SV Angel, CrunchFund, Marker, Howard Lerman and others.
- Genability, Inc., a new energy software company, landed $3 million investment from WindSail Capital Group, a Boston-based investment firm that provides growth financing to companies advancing energy innovation and sustainability. WindSail’s investment will allow Genability to continue its fast growth in rooftop and community solar, as well as electric vehicles, behind the meter storage, and connected homes and buildings.
- Resolver Inc., a Toronto, CA-based provider of risk and incident management software, raised an additional $4 million growth equity funding. Existing backer Klass Capital made the investment. The company, which has now raised $18m in total funding, intends to use the funds to accelerate product plans and continue to enhance its SaaS-based integrated risk offerings.
- Penrose Studios, a virtual reality media company created by the co-founder of Oculus Story Studios Eugene Chung, raised $8.5 million from multiple investors, including Accelerate-IT Ventures, TransLink Capital, Suffolk Equity and 8 Angel. It’s the company’s first funding round. Chung says the money will be used to do the same kinds of things most startups do: add to its headcount and invest in more projects.
- Avametric, a fashion software company, raised $10.5 million in a funding round led by Khosla Ventures to bring its product to the retail market. In addition to the funding, the company has brought on board fashion industry veteran Kendra Gratteri as its chief customer officer. Khosla Ventures partner Keith Rabois and Google’s vice president and head of Project, Aura Ivy Ross, have also joined the board.
- Icertis, a provider of contract lifecycle management in the Cloud, closed $15 million in Series B funding led by Ignition Partners, with super pro-rata participation from all existing investors, Greycroft Partners and Fidelity Growth Partners India. John Connors, managing partner at Ignition Partners and former CIO and CFO at Microsoft, will also join its Board of Directors. This new round brings the company's total funding to $21 million. Icertis will use the funds to expand its global operations, invest in marketing, and further enhance the Icertis Contract Management (ICM) platform to widen its leadership position.
- Attivio, a Massachusetts-based startup that promises to “accelerate data discovery,”closed a $31 million financing round. The investment, the startup said, will help the company to meet investors’ expectation of turning profitable “later this year. Oak Investment Partners, General Electric Pension Trust, and Tenth Avenue Holdings participated in the investment, which pushed Attivio’s funding to at least $102 million.
- Aspyrian Therapeutics Inc., a San Diego, CA-based clinical stage drug development company, raised $40 million in Series B financing. Hiroshi Mikitani, the CEO of Rakuten, Inc., made the investment through his personal companies. Mikitani is also a Director of Aspyrian Therapeutics’ board. The company intends to use the funds to accelerate clinical development efforts of the antibody conjugate RM-1929 towards approval and commercialization in recurrent head and neck cancer as well as other cancer areas.
If you are interested in being included in our funding roundup, submit your press release or blog post about your financing round to email@example.com.
Image source: techinasia.com